Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

Updated clinical recommendations, including lifestyle changes, prevention strategies and treatment options, to reduce the risk of a first stroke have been outlined in a new guideline.

Neurophet, an artificial intelligence (AI) solution company for brain disease, hosted Neurophet Symposium with Professor ...

A new study published in the journal of Audiology Research found the intricate connections between hearing loss, central ...

A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has granted marketing authorization of DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adult and pediatric ...

Alzamend Neuro, Inc. ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the ...